NRF2 signaling drives chemoresistance in NSCLC and glioblastoma.
de Souza I, Monteiro LKS, da Silva Teixeira AB, Guedes CB, Lima KA, de Souza Filho CHD, de Andrade IAM, Ramalho MCC, de Oliveira BS, Lazarini M, Rocha CRR
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.